Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
183
3.960
Why?
Proteins
17
2010
340
2.390
Why?
Neovascularization, Pathologic
17
2022
155
2.360
Why?
Calixarenes
7
2017
9
1.900
Why?
Melanoma, Experimental
6
2021
40
1.790
Why?
Galectin 1
8
2024
20
1.780
Why?
Antineoplastic Agents
14
2024
1165
1.550
Why?
Peptides
20
2017
220
1.340
Why?
Mice
47
2024
5659
1.270
Why?
Neoplasms
14
2024
1248
1.190
Why?
Animals
53
2024
13063
1.040
Why?
Endothelial Cells
10
2022
256
1.030
Why?
Lung Neoplasms
5
2024
597
1.020
Why?
Ovarian Neoplasms
8
2008
449
0.860
Why?
Gold
7
2023
128
0.860
Why?
Oxygen
6
2020
319
0.830
Why?
Cell Line, Tumor
18
2024
1393
0.790
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
153
0.760
Why?
Carcinoma, Squamous Cell
4
2019
326
0.730
Why?
Proto-Oncogene Proteins c-met
1
2021
18
0.720
Why?
Peptide Fragments
5
2013
208
0.700
Why?
Mammary Neoplasms, Experimental
6
2015
121
0.700
Why?
Radiation-Sensitizing Agents
4
2023
51
0.690
Why?
Head and Neck Neoplasms
3
2019
288
0.670
Why?
Carcinoma, Lewis Lung
1
2019
9
0.650
Why?
Molecular Targeted Therapy
2
2018
122
0.630
Why?
Protein Kinase Inhibitors
1
2021
204
0.630
Why?
Preservation, Biological
1
2018
8
0.620
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
77
0.620
Why?
Anti-Bacterial Agents
4
2019
751
0.620
Why?
Radiation Tolerance
5
2020
84
0.610
Why?
CD8-Positive T-Lymphocytes
1
2019
127
0.610
Why?
Galectins
1
2018
5
0.590
Why?
Metal Nanoparticles
4
2023
80
0.560
Why?
Hyperthermia, Induced
3
2019
115
0.550
Why?
Bacteria
1
2018
210
0.540
Why?
Mice, Nude
12
2019
247
0.530
Why?
Radiotherapy
5
2021
125
0.530
Why?
Xenograft Model Antitumor Assays
11
2020
210
0.500
Why?
Pseudomonas aeruginosa
2
2013
71
0.470
Why?
Combined Modality Therapy
11
2020
640
0.420
Why?
Benzofurans
2
2012
18
0.420
Why?
Cytotoxins
1
2013
15
0.410
Why?
Cell Proliferation
10
2024
980
0.410
Why?
Pseudomonas Infections
1
2013
49
0.400
Why?
Oxidation-Reduction
3
2024
313
0.400
Why?
Drug Design
4
2014
119
0.400
Why?
Endothelium, Vascular
8
2010
244
0.400
Why?
Humans
44
2024
50419
0.400
Why?
Carbohydrate Metabolism
1
2012
26
0.390
Why?
Neoplasms, Experimental
4
2020
111
0.380
Why?
Nanostructures
3
2023
45
0.380
Why?
Benzeneacetamides
2
2024
12
0.380
Why?
Glutaminase
2
2024
18
0.380
Why?
Bacteremia
1
2013
89
0.380
Why?
Sesquiterpenes
3
2010
87
0.360
Why?
Angiostatic Proteins
1
2011
1
0.360
Why?
Immunity, Cellular
1
2011
68
0.350
Why?
Cell Survival
8
2024
587
0.350
Why?
Molecular Mimicry
2
2007
38
0.350
Why?
Dendritic Cells
3
2021
135
0.340
Why?
Endothelium
4
2022
37
0.330
Why?
Carboplatin
3
2024
54
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
997
0.320
Why?
Tumor Necrosis Factor-alpha
4
2019
386
0.320
Why?
Immunotherapy, Adoptive
1
2011
161
0.310
Why?
Cells, Cultured
8
2013
1563
0.310
Why?
Apoptosis
7
2024
1092
0.310
Why?
Vascular Endothelial Growth Factor A
7
2022
180
0.310
Why?
Intercellular Adhesion Molecule-1
5
2022
61
0.300
Why?
T-Lymphocytes
1
2011
325
0.300
Why?
Structure-Activity Relationship
6
2012
391
0.300
Why?
Polyethylene Glycols
3
2021
84
0.300
Why?
Mice, Inbred C57BL
8
2021
1796
0.300
Why?
Phototherapy
2
2019
43
0.290
Why?
Amino Acid Sequence
5
2012
575
0.290
Why?
Tumor Cells, Cultured
6
2019
453
0.280
Why?
Female
24
2020
27053
0.280
Why?
Drug Resistance, Neoplasm
2
2024
315
0.270
Why?
Magnetic Resonance Spectroscopy
5
2012
242
0.260
Why?
Antibodies, Monoclonal
2
2007
460
0.260
Why?
Blood Vessels
4
2015
71
0.260
Why?
Disease Models, Animal
7
2020
1431
0.250
Why?
Molecular Sequence Data
5
2012
760
0.250
Why?
Nanoparticles
2
2017
148
0.230
Why?
Cell Division
7
2010
292
0.230
Why?
Bystander Effect
1
2024
25
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
90
0.220
Why?
Cysteine
1
2024
50
0.220
Why?
Buthionine Sulfoximine
1
2024
13
0.220
Why?
Nanotubes
2
2021
27
0.220
Why?
Models, Molecular
4
2024
333
0.220
Why?
Thiadiazoles
2
2024
18
0.210
Why?
Flow Cytometry
2
2017
472
0.200
Why?
Cisplatin
1
2024
283
0.190
Why?
Alanine
3
2012
43
0.190
Why?
Protein Binding
3
2012
648
0.190
Why?
Carcinoma, Renal Cell
1
2022
101
0.190
Why?
Binding Sites
2
2012
362
0.190
Why?
Optical Imaging
2
2020
22
0.180
Why?
Silver
2
2021
48
0.180
Why?
Kidney Neoplasms
1
2022
174
0.180
Why?
Polyurethanes
1
2021
10
0.180
Why?
Radiation
1
2020
15
0.180
Why?
Forkhead Transcription Factors
1
2021
110
0.180
Why?
Materials Testing
1
2021
56
0.180
Why?
Spectrum Analysis
1
2020
70
0.170
Why?
Biocompatible Materials
1
2021
66
0.170
Why?
Mice, Inbred BALB C
5
2020
293
0.170
Why?
Mice, Knockout
3
2012
840
0.170
Why?
CD4-Positive T-Lymphocytes
1
2021
158
0.170
Why?
Neoplasm Transplantation
5
2007
83
0.170
Why?
Disease Progression
3
2019
825
0.160
Why?
Oxygen Consumption
1
2020
191
0.160
Why?
Lactose
2
2024
9
0.160
Why?
Immunotherapy
1
2020
234
0.150
Why?
Spectrum Analysis, Raman
1
2019
55
0.150
Why?
Specimen Handling
1
2018
55
0.150
Why?
Biological Assay
1
2018
45
0.150
Why?
Time Factors
6
2017
2933
0.150
Why?
Drug Delivery Systems
2
2019
143
0.150
Why?
Feces
1
2018
138
0.150
Why?
Indazoles
1
2018
46
0.150
Why?
Carbohydrates
1
2018
39
0.150
Why?
Temperature
1
2018
157
0.150
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
57
0.140
Why?
Cell Hypoxia
4
2015
82
0.140
Why?
Histocompatibility Antigens Class II
1
2017
37
0.140
Why?
Tumor Microenvironment
1
2019
221
0.140
Why?
Male
9
2019
25866
0.130
Why?
Drug Therapy, Combination
1
2018
387
0.130
Why?
Epithelial Cells
1
2018
203
0.130
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Cell Line
4
2017
997
0.130
Why?
Lipopolysaccharides
2
2008
196
0.130
Why?
Umbilical Veins
4
2010
21
0.130
Why?
Enzyme Inhibitors
1
2018
369
0.130
Why?
Leukocytes
3
2006
69
0.120
Why?
Molecular Imaging
1
2015
54
0.120
Why?
Azides
1
2014
10
0.120
Why?
Fluorine Radioisotopes
1
2014
24
0.120
Why?
Tumor Burden
2
2013
130
0.120
Why?
Cell Transformation, Neoplastic
2
2007
182
0.120
Why?
Immunohistochemistry
5
2020
955
0.110
Why?
Interleukin-2
2
2021
70
0.110
Why?
Drug Synergism
2
2005
149
0.110
Why?
Cell Adhesion
3
2006
155
0.110
Why?
Piperacillin
1
2013
23
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
20
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
13
0.100
Why?
Inflammation Mediators
1
2013
110
0.100
Why?
Cell Cycle
1
2013
227
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
28
0.090
Why?
Up-Regulation
2
2011
446
0.090
Why?
Neoplastic Stem Cells
1
2012
97
0.090
Why?
Metformin
1
2012
67
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Fibroblasts
1
2013
338
0.090
Why?
Glutamine
2
2024
175
0.090
Why?
Adjuvants, Immunologic
1
2011
52
0.090
Why?
Chemotherapy, Adjuvant
1
2011
119
0.090
Why?
Cell Movement
4
2006
244
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
602
0.080
Why?
Lignans
1
2008
6
0.080
Why?
Salmonella typhimurium
1
2008
45
0.080
Why?
Klebsiella pneumoniae
1
2008
19
0.070
Why?
Amino Acid Substitution
1
2008
81
0.070
Why?
Furans
1
2008
27
0.070
Why?
Escherichia coli
1
2008
176
0.070
Why?
Surface Properties
1
2007
71
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Endotoxins
1
2006
30
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
32
0.070
Why?
Protein Structure, Secondary
2
2003
71
0.070
Why?
Interleukin-8
1
2006
85
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
17
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
224
0.060
Why?
Cloning, Molecular
1
2005
190
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
138
0.060
Why?
Angiogenic Proteins
1
2004
6
0.060
Why?
Colonic Neoplasms
1
2006
156
0.060
Why?
Histones
1
2006
294
0.060
Why?
Dietary Supplements
1
2008
449
0.060
Why?
Protein Unfolding
1
2024
6
0.060
Why?
Feasibility Studies
1
2006
389
0.060
Why?
Disulfides
1
2024
15
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Mutagenesis, Site-Directed
1
2024
96
0.060
Why?
Protein Folding
1
2024
45
0.060
Why?
Mammary Neoplasms, Animal
1
2004
35
0.060
Why?
Osmosis
1
2003
5
0.050
Why?
Infusion Pumps
1
2003
13
0.050
Why?
Circular Dichroism
1
2003
41
0.050
Why?
Plasminogen
1
2003
2
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1369
0.050
Why?
Serum Albumin
1
2003
57
0.050
Why?
Extracellular Matrix
1
2003
109
0.050
Why?
Immune Tolerance
1
2022
83
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
831
0.050
Why?
Reactive Oxygen Species
1
2024
408
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
269
0.050
Why?
Immunity
1
2021
34
0.050
Why?
Immune System
1
2021
43
0.050
Why?
Melanoma
1
2004
278
0.050
Why?
Ethers
1
2021
8
0.040
Why?
Regenerative Medicine
1
2021
10
0.040
Why?
Tissue Scaffolds
1
2021
35
0.040
Why?
Angiogenesis Inducing Agents
1
2000
8
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
183
0.040
Why?
Tissue Engineering
1
2021
65
0.040
Why?
Adenocarcinoma
1
2004
396
0.040
Why?
Bone Marrow Cells
1
2021
195
0.040
Why?
Mice, Inbred C3H
2
2012
85
0.040
Why?
Gene Expression Profiling
1
2004
1020
0.040
Why?
Skin Neoplasms
1
2004
492
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
Inflammation
1
2022
607
0.040
Why?
NAD
1
2018
41
0.040
Why?
Microcirculation
2
2010
64
0.040
Why?
Guidelines as Topic
1
2018
110
0.040
Why?
Glutathione
1
2019
297
0.040
Why?
Microscopy, Fluorescence
1
2018
160
0.040
Why?
Phagocytosis
1
2017
49
0.030
Why?
Glycolysis
1
2017
69
0.030
Why?
Transplantation, Heterologous
2
2008
73
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
25
0.030
Why?
Stromal Cells
1
2015
75
0.030
Why?
Cell Count
1
2015
150
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Down-Regulation
2
2006
338
0.030
Why?
Paclitaxel
2
2006
84
0.030
Why?
Drug Evaluation, Preclinical
1
2015
144
0.030
Why?
Radiochemistry
1
2014
1
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
284
0.030
Why?
Recombinant Proteins
2
2006
477
0.030
Why?
Cell Differentiation
1
2017
640
0.030
Why?
Radiotherapy Dosage
1
2015
248
0.030
Why?
Imaging, Three-Dimensional
1
2015
151
0.030
Why?
Contrast Media
1
2015
191
0.030
Why?
Molecular Structure
1
2014
293
0.030
Why?
Ultrasonography
1
2015
434
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
326
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
9
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
76
0.020
Why?
Rats
2
2008
3262
0.020
Why?
Radiometry
1
2012
123
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
22
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
115
0.020
Why?
Receptors, Progesterone
1
2008
64
0.020
Why?
Estrogen Receptor beta
1
2008
56
0.020
Why?
Estrogen Receptor alpha
1
2008
90
0.020
Why?
Cell Growth Processes
1
2007
22
0.020
Why?
Carcinogens
1
2008
196
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
20
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
68
0.020
Why?
DNA Modification Methylases
1
2006
27
0.020
Why?
Endotoxemia
1
2006
33
0.020
Why?
Acetylation
1
2006
94
0.020
Why?
Methylation
1
2006
117
0.020
Why?
Vimentin
1
2006
31
0.020
Why?
Chick Embryo
1
2006
83
0.020
Why?
Gene Silencing
1
2006
114
0.020
Why?
Blood Proteins
1
2006
83
0.020
Why?
Nucleic Acid Hybridization
1
2006
56
0.020
Why?
Transfection
1
2007
353
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Zebrafish
1
2006
54
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
56
0.020
Why?
Histone Deacetylases
1
2006
51
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
37
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
41
0.020
Why?
Cyclophosphamide
1
2006
168
0.020
Why?
Neovascularization, Physiologic
1
2005
68
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
43
0.010
Why?
Membrane Proteins
1
2006
337
0.010
Why?
Indoles
1
2007
277
0.010
Why?
Skin
1
2007
382
0.010
Why?
Treatment Outcome
1
2014
5265
0.010
Why?
Necrosis
1
2004
173
0.010
Why?
Antibodies
1
2004
151
0.010
Why?
In Situ Nick-End Labeling
1
2003
52
0.010
Why?
Base Sequence
1
2004
622
0.010
Why?
Sequence Homology, Amino Acid
1
2003
141
0.010
Why?
Epigenesis, Genetic
1
2006
371
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
568
0.010
Why?
Mice, Transgenic
1
2004
537
0.010
Why?
RNA, Messenger
1
2004
1085
0.010
Why?
Endothelial Growth Factors
1
2000
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
13
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
19
0.010
Why?
Scrotum
1
2000
30
0.010
Why?
Interleukin-1
1
2000
104
0.010
Why?
Models, Biological
1
2002
717
0.010
Why?
Breast Neoplasms
1
2004
1198
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description